fluorodopa f 18 has been researched along with Intellectual Disability in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bours, V; Caberg, JH; Dive, D; Garraux, G; Jamar, M; Moonen, G; Vanbellinghen, JF | 1 |
Biraben, A; Depaulis, A; Douaud, G; Remy, P; Ribeiro, MJ; Semah, F | 1 |
2 other study(ies) available for fluorodopa f 18 and Intellectual Disability
Article | Year |
---|---|
Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
Topics: Adult; Age of Onset; alpha-Synuclein; Antiparkinson Agents; Chromosomes, Human, Pair 4; Dihydroxyphenylalanine; Dopamine Agonists; Female; Gene Duplication; Humans; Intellectual Disability; Karyotyping; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Trisomy | 2012 |
PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Caudate Nucleus; Chromosome Disorders; Chromosomes, Human, Pair 20; Dihydroxyphenylalanine; Dopamine; Drug Resistance; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fear; Female; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Ring Chromosomes; Status Epilepticus; Synaptic Transmission | 2004 |